Estée Lauder Companies

Consumer GoodsBeauty & CosmeticsRetail

18 provisions tracked

6 positive

5 negative

1 conflict

NegativeSec. FDA-2026-N-0891 · Consumer & Trade

FDA Cosmetics Modernization and Safety Act (MoCRA Phase 2)

Fragrance allergen labeling requires reformulation or relabeling of 2,400+ SKUs across Estée Lauder, Clinique, Tom Ford, and Le Labo brands. PFAS restrictions affect 340+ products using fluorinated compounds. Compliance cost: $280M over 3 years. BUT: competitive moat — smaller brands face proportionally higher costs.

ACTION: File detailed comments supporting science-based allergen thresholds. Advocate for 36-month implementation timeline (vs. proposed 24 months). Brief Cantwell and Eshoo on U.S. manufacturing impact. Coordinate with PCPC trade group on industry position.

FDA enforcement budget: $85M over 3 years

IndirectSec. CMS-2026-0089 · Healthcare & Pharma

IRA Drug Price Negotiation — Round 3 Expansion

No direct impact. Healthcare spending reduction may marginally increase consumer discretionary spending on beauty and personal care products.

$12.4B estimated savings over 10 years

IndirectSec. S-2891 · Technology & Telecom

Comprehensive Federal Data Privacy Act (CFPA)

E-commerce and DTC operations affected by targeted advertising opt-out. Beauty industry relies heavily on personalized digital marketing. Impact moderate given diversified retail channel strategy.

FTC enforcement budget: $350M over 5 years

PositiveSec. HR-5389 · Tax & Economic Policy

R&D Tax Credit Permanence and Expansion Act

Estée Lauder's $420M annual R&D spend on skincare formulation and manufacturing innovation qualifies. Manufacturing process credit benefits 13 global facilities, 5 in the U.S.

ACTION: Support through PCPC trade group. Brief Suozzi on NY manufacturing impact.

$185B tax expenditure over 10 years

PositiveSec. EO-2026-14178 · Trade & Tariffs

Executive Order — Section 301 Tariff Review (China Trade)

Section 301 tariffs currently apply 25% duties on $1.2B of Estée Lauder's China-sourced packaging, raw materials, and components. Tariff reduction or exclusion would improve margins by estimated $180M annually. China market access improvements could boost $2.8B market revenue.

ACTION: File tariff exclusion requests through USTR docket. Brief Cantwell on cosmetics industry supply chain impacts. Coordinate with PCPC on industry-wide tariff reduction advocacy.